Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossein Borghaei

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Advances in immune checkpoint inhibition for patients with lung cancerHossein Borghaei
Oncotargets and Therapy|July 10, 2010
Rational use of cetuximab in the treatment of advanced non-small cell lung cancerCharu Aggarwal, Hossein Borghaei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2021
To Give or Not to Give: Consolidative Durvalumab in EGFR-Mutant NSCLCJessica Bauman, Hossein Borghaei
Cancer Investigation|October 6, 2005
Comment on "Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study," by Kahl et al., Cancer Investigation, 2005, 23(1), pp. 13-18Mitchell Smith, Hossein Borghaei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2025
Leptomeningeal Disease in Lung Cancer: An Unmet Need That Needs to Be MetHossein Borghaei, Tony Mok
Thoracic Surgery Clinics|April 25, 2020
Combining Immunotherapy and Chemotherapy for Non-Small Cell Lung CancerJulia Judd, Hossein Borghaei
The Oncologist|April 15, 2017
Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint DesignCharu Aggarwal, Hossein Borghaei
Pharmacogenomics and Personalized Medicine|December 11, 2012
Personalized medicine and treatment approaches in non-small-cell lung carcinomaJoseph Vadakara, Hossein Borghaei
The New England Journal of Medicine|February 4, 2016
Nivolumab in Nonsquamous Non-Small-Cell Lung CancerHossein Borghaei, Julie Brahmer
JAMA Network Open|June 9, 2020
Biomarker Testing in Lung Cancer-What Does It Mean?Hossein Borghaei, Martin J Edelman
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Advances in immune checkpoint inhibition for patients with lung cancerHossein Borghaei
Oncotargets and Therapy|July 10, 2010
Rational use of cetuximab in the treatment of advanced non-small cell lung cancerCharu Aggarwal, Hossein Borghaei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2021
To Give or Not to Give: Consolidative Durvalumab in EGFR-Mutant NSCLCJessica Bauman, Hossein Borghaei
Cancer Investigation|October 6, 2005
Comment on "Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study," by Kahl et al., Cancer Investigation, 2005, 23(1), pp. 13-18Mitchell Smith, Hossein Borghaei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2025
Leptomeningeal Disease in Lung Cancer: An Unmet Need That Needs to Be MetHossein Borghaei, Tony Mok
Thoracic Surgery Clinics|April 25, 2020
Combining Immunotherapy and Chemotherapy for Non-Small Cell Lung CancerJulia Judd, Hossein Borghaei
The Oncologist|April 15, 2017
Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint DesignCharu Aggarwal, Hossein Borghaei
Pharmacogenomics and Personalized Medicine|December 11, 2012
Personalized medicine and treatment approaches in non-small-cell lung carcinomaJoseph Vadakara, Hossein Borghaei
The New England Journal of Medicine|February 4, 2016
Nivolumab in Nonsquamous Non-Small-Cell Lung CancerHossein Borghaei, Julie Brahmer
JAMA Network Open|June 9, 2020
Biomarker Testing in Lung Cancer-What Does It Mean?Hossein Borghaei, Martin J Edelman
Pageof 16